investor harm

Class action filed against Masonite alleging undisclosed Owens Corning acquisition offers while company repurchased stock at depressed prices.

Class action filed against CoreWeave ($CRWV) alleging executives made false statements about operational capabilities and customer demand fulfillment between March-December 2025. Lead plaintiff deadline: March 13, 2026.

Class action lawsuit filed against Kyndryl Holdings for alleged securities fraud, false financial disclosures, and internal control failures. Lead plaintiff deadline set for April 13, 2026.

Class action lawsuit filed against PayPal alleging executives made false statements about revenue projections and 2027 targets under CEO James Chriss.

Class action lawsuit filed against $VTGN alleges securities fraud over misleading statements about fasedienol drug candidate and PALISADE-3 clinical trial data.

Class action filed against $PMI alleging securities fraud, false promotion, and insider share dumping via offshore accounts. Investors have until April 2026 to join.

Soleno Therapeutics faces class action lawsuit alleging failure to disclose safety concerns about DCCR drug candidate from clinical trials.

Class action lawsuit filed against Paysafe alleging failure to disclose high-risk client exposure, understated credit reserves, and merchant category issues.

Class action filed against Ultragenyx ($RARE) alleging misrepresented setrusumab trial data. Investors purchasing August 2023-December 2025 may recover damages.

Class action lawsuit filed against BellRing Brands alleging materially false statements about sales driven by inventory accumulation rather than genuine demand.

Class action lawsuit filed against AMC over alleged securities violations regarding APE preferred equity units and distribution rights.

Class action lawsuit filed against $PLUG alleging false statements about DOE loan availability and hydrogen facility construction capability.

Bath & Body Works faces class action lawsuit alleging executives made false statements about growth strategy effectiveness. Lead plaintiff deadline is March 13, 2026.

Class action filed against $BSX alleging executives misrepresented U.S. electrophysiology segment sustainability. Claims executives concealed adverse trends, competitive pressures, regulatory challenges.

Class action filed against Lakeland Industries alleging executives misrepresented Pacific Helmets and Jolly performance while hiding operational issues including shipping delays and tariff pressures.

Class action filed against $SDM alleging market manipulation, social media fraud, and insider share dumping. Investors who bought between May-September 2025 eligible to join.

Mereo BioPharma faces class action over failed Phase 3 trials and alleged misleading statements. Investor deadline April 6, 2026.

Class action filed against Ramaco Resources ($METC) alleging executives made false statements about Brook Mine development progress, affecting investors from July-October 2025.

Snowflake faces class action alleging company concealed material information about product changes harming revenue while making misleading positive statements through early 2024.

Class action lawsuit filed against REGENXBIO alleging false statements about RGX-111 gene therapy. Covers investors from Feb 2022 to Jan 2026; lead plaintiff deadline April 14.